Colorado Rights Blog

HB20-1065:Harm Reduction Substance Use Disorders

Protect Patient Health
Bill Number: HB20-1065
Year: 2020
ACLU Position: Support
Sponsors: C. Kennedy / L. Herod /K. Priola / B. Pettersen


Opioid and Other Substance Use Disorders Study Committee.
The bill:
• Requires a carrier that provides coverage for opiate
antagonists to reimburse a hospital if the hospital provides
a covered person with an opiate antagonist upon discharge
(section 1 of the bill);
• Allows a pharmacist or pharmacy technician to sell a
nonprescription syringe or needle to any person (sections
2 and 5
• Extends civil and criminal immunity for a person who acts
in good faith to furnish or administer an opiate antagonist
to an individual the person believes to be suffering an
opiate-related drug overdose when the opiate antagonist
was expired (sections 3 and 4);
• Removes the requirement that entities first receive local
board of health approval before operating a clean syringe
exchange program (sections 6 and 7); and
• Provides that money in the harm reduction grant program
cash fund is continuously appropriated to the department of
public health and environment for purposes of the harm
reduction grant program and establishes an annual
appropriation of an amount equal to the appropriation for
the 2019-20 fiscal year plus $250,000 (section 8).

Current Status:

Sent to the Governor (06/29/2020)
Senate Third Reading Passed - No Amendments (06/11/2020)
Introduced In Senate - Assigned to State, Veterans, & Military Affairs (06/09/2020)
House Third Reading Passed - No Amendments (06/09/2020)
House Committee on Health & Insurance Refer Amended to Appropriations (02/19/20)
Introduced In House - Assigned to Health & Insurance (01/08/2020)

Return to Search Menu